Filter
1696
Filtered Results: 1696
Text search:
Africa
CDC
Centers
for
Disease
Control
and
Prevention
Featured
Recommendations
219
New Publications
421
Language
Document type
No document type
849
Guidelines
256
Studies & Reports
229
Manuals
107
Fact sheets
83
Strategic & Response Plan
79
Training Material
34
Infographics
19
Brochures
15
Situation Updates
14
Resource Platforms
11
Countries / Regions
Africa
118
West and Central Africa
86
Sierra Leone
67
East and Southern Africa
65
Middle East and North Africa
64
Liberia
64
Global
62
Nigeria
52
Kenya
50
Ethiopia
47
Mozambique
42
Uganda
36
South Africa
33
Guinea
32
Rwanda
31
Tanzania
31
South Sudan
30
Angola
29
Namibia
28
Zambia
28
Senegal
26
Malawi
25
Ghana
23
Yemen
23
Guinea-Bissau
22
Congo, Democratic Republic of
22
Syria
21
Zimbabwe
16
Burkina Faso
15
India
14
Côte d’Ivoire / Ivory Coast
13
Madagascar
13
Brazil
12
Latin America and the Carribbean
10
Western and Central Europe
10
Mali
10
Nepal
9
Botswana
9
Cameroon
8
Asia
8
Russia
8
Eswatini/ Swaziland
8
Lesotho
7
Germany
7
Bangladesh
7
Vietnam
6
Eastern Europe
6
Colombia
5
Ukraine
5
Benin
5
Togo
5
Niger
5
USA
5
Central African Republic
5
Chad
5
Venezuela
4
Paraguay
4
Portugal
4
Pakistan
4
Gambia
3
China
3
Philippines
3
Saudi Arabia
3
South–East Asia Region
3
France
3
Somalia
3
Thailand
2
Afghanistan
2
Burundi
2
Cambodia
2
Western Pacific Region
2
Tunisia
2
Egypt
2
Sudan
2
Indonesia
2
Iraq
2
Mexico
1
Turkey
1
Congo-Brazzaville
1
Peru
1
Malaysia
1
Morocco
1
Qatar
1
Haiti
1
Cape Verde
1
Jordan
1
North America
1
Gabon
1
Japan
1
Mauritius
1
United Kingdom
1
Spain
1
South Korea
1
Morocco
1
Southern Africa
1
Bolivia
1
Argentina
1
Lebanon
1
Djibouti
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
676
Clinical Guidelines
141
Key Resources
95
Public Health
79
Women & Child Health
52
Pharmacy & Technologies
29
Capacity Building
27
Toolboxes
COVID-19
323
HIV
160
Ebola & Marburg
147
TB
118
Rapid Response
103
AMR
64
NTDs
37
Mental Health
35
Zika
35
Planetary Health
27
NCDs
25
2.0 Rapid Response
25
Caregiver
24
Malaria
23
Refugee
18
Pharmacy
18
Health Financing Toolbox
16
Polio
16
Global Health Education
16
Cholera
12
Disability
8
Natural Hazards
7
Conflict
7
Specific Hazards
6
Social Ethics
1
This document is the national level companion to a broader document on health care facility level developed by the WHO Health Emergencies Programme for national level stakeholders
Infectious disease outbreaks and epidemics are increasing in frequency, scale and impact. Health care facilities can amplify the transmission of emerging infectious diseases or multidrug-resistant organisms (MDRO) within their settings and communities. Therefore, evidence-based infection prevention ...
To guide One Health capacity building efforts in the Republic of Guinea in the wake of the 2014–2016 Ebola virus disease (EVD) outbreak, we sought to identify and assess the existing systems and structures for zoonotic disease detection and control. We partnered with the government ministries resp...
Report of a WHO technical consultation meeting
Ouagadougou, Burkina Faso
This article summarises the process involved in developing the updated guideline and includes an infographic to highlight key IPC recommendations from the guideline, following the patient care pathway from the community to a healthcare facility to discharge.
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp...
The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac...
The World Health Organization (WHO) Global Status Report on Noncommunicable Diseases 2010 projects that noncommunicable diseases (NCDs) will be responsible for over 44 million deaths during the next decade, representing an increase of about 15% since 2010. Most of these deaths will occur in the WHO ...
Morbidity and Mortality Weekly Report (MMWR) October 4, 2019 / 68(39);851–854
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1...
The strategic framework gives guidance to public and private health facilities and health workers on compliance with standards relating to IPC practices. To further assist health facilities to implement the IPC strategic framework, this practical implementation manual has been developed in parallel ...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
